Arcadia Biosciences, Inc. (NASDAQ: RKDA) Stock Competitors & Peer Comparison
See RKDA's competitors and their performance on the NASDAQ and across the wider stock market.
Peer Comparison Table: Agricultural Inputs Industry
Detailed financial metrics including price, market cap, P/E ratio, and more for RKDA and its NASDAQ peers.
| Symbol | Price | Change % | Market Cap | P/E Ratio | EPS | Dividend Yield |
|---|---|---|---|---|---|---|
| RKDA | $0.22 | -1.80% | 337.3K | -0.05 | -$4.56 | N/A |
| VYLR | $72.54 | +0.67% | 48.4B | 103.63 | $0.70 | N/A |
| CTA-PA | $44.26 | -1.64% | 43B | N/A | N/A | +1.16% |
| NTR | $71.24 | +0.03% | 33.8B | 14.48 | $4.92 | +3.07% |
| CF | $125.09 | +0.14% | 18.3B | 9.00 | $13.90 | +1.68% |
| MOS | $21.92 | +0.74% | 7B | 15.22 | $1.44 | +4.04% |
| CTVA | $9.43 | +2.61% | 6.3B | 2.56 | $3.69 | +1.16% |
| CTA-PB | $54.21 | -1.86% | 6.1B | N/A | N/A | +1.16% |
| ICL | $4.52 | -1.53% | 5.8B | 10.74 | $0.42 | +4.55% |
| SMG | $63.84 | +0.16% | 3.7B | 14.54 | $4.39 | +4.12% |
Stock Comparison
Vylor Inc. (NYSE: VYLR)
RKDA vs VYLR Comparison November 2026
Arcadia Biosciences, Inc. (NASDAQ: RKDA) plays a significant role within the Basic Materials sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RKDA stands at 337.3K. In comparison, VYLR has a market cap of 48.4B. Regarding current trading prices, RKDA is priced at $0.22 on the NASDAQ, while VYLR trades at $72.54.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RKDA currently has a P/E ratio of -0.05, whereas VYLR's P/E ratio is 103.63. In terms of profitability, RKDA's ROE is -4.07%, compared to VYLR's ROE of +0.05%. Regarding short-term risk, RKDA is more volatile compared to VYLR. This indicates higher risk in terms of short-term price fluctuations for RKDA.Check VYLR's competition here
EIDP, Inc. (NYSE: CTA-PA)
RKDA vs CTA-PA Comparison November 2026
Arcadia Biosciences, Inc. (NASDAQ: RKDA) plays a significant role within the Basic Materials sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RKDA stands at 337.3K. In comparison, CTA-PA has a market cap of 43B. Regarding current trading prices, RKDA is priced at $0.22 on the NASDAQ, while CTA-PA trades at $44.26.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RKDA currently has a P/E ratio of -0.05, whereas CTA-PA's P/E ratio is N/A. In terms of profitability, RKDA's ROE is -4.07%, compared to CTA-PA's ROE of +0.03%. Regarding short-term risk, RKDA is more volatile compared to CTA-PA. This indicates higher risk in terms of short-term price fluctuations for RKDA.Check CTA-PA's competition here
Nutrien Ltd. (NYSE: NTR)
RKDA vs NTR Comparison November 2026
Arcadia Biosciences, Inc. (NASDAQ: RKDA) plays a significant role within the Basic Materials sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RKDA stands at 337.3K. In comparison, NTR has a market cap of 33.8B. Regarding current trading prices, RKDA is priced at $0.22 on the NASDAQ, while NTR trades at $71.24.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RKDA currently has a P/E ratio of -0.05, whereas NTR's P/E ratio is 14.48. In terms of profitability, RKDA's ROE is -4.07%, compared to NTR's ROE of +0.09%. Regarding short-term risk, RKDA is more volatile compared to NTR. This indicates higher risk in terms of short-term price fluctuations for RKDA.Check NTR's competition here
CF Industries Holdings, Inc. (NYSE: CF)
RKDA vs CF Comparison November 2026
Arcadia Biosciences, Inc. (NASDAQ: RKDA) plays a significant role within the Basic Materials sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RKDA stands at 337.3K. In comparison, CF has a market cap of 18.3B. Regarding current trading prices, RKDA is priced at $0.22 on the NASDAQ, while CF trades at $125.09.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RKDA currently has a P/E ratio of -0.05, whereas CF's P/E ratio is 9.00. In terms of profitability, RKDA's ROE is -4.07%, compared to CF's ROE of +0.40%. Regarding short-term risk, RKDA is more volatile compared to CF. This indicates higher risk in terms of short-term price fluctuations for RKDA.Check CF's competition here
The Mosaic Company (NYSE: MOS)
RKDA vs MOS Comparison November 2026
Arcadia Biosciences, Inc. (NASDAQ: RKDA) plays a significant role within the Basic Materials sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RKDA stands at 337.3K. In comparison, MOS has a market cap of 7B. Regarding current trading prices, RKDA is priced at $0.22 on the NASDAQ, while MOS trades at $21.92.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RKDA currently has a P/E ratio of -0.05, whereas MOS's P/E ratio is 15.22. In terms of profitability, RKDA's ROE is -4.07%, compared to MOS's ROE of -0.04%. Regarding short-term risk, RKDA is more volatile compared to MOS. This indicates higher risk in terms of short-term price fluctuations for RKDA.Check MOS's competition here
Corteva, Inc. (NYSE: CTVA)
RKDA vs CTVA Comparison November 2026
Arcadia Biosciences, Inc. (NASDAQ: RKDA) plays a significant role within the Basic Materials sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RKDA stands at 337.3K. In comparison, CTVA has a market cap of 6.3B. Regarding current trading prices, RKDA is priced at $0.22 on the NASDAQ, while CTVA trades at $9.43.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RKDA currently has a P/E ratio of -0.05, whereas CTVA's P/E ratio is 2.56. In terms of profitability, RKDA's ROE is -4.07%, compared to CTVA's ROE of +0.03%. Regarding short-term risk, RKDA is more volatile compared to CTVA. This indicates higher risk in terms of short-term price fluctuations for RKDA.Check CTVA's competition here
EIDP, Inc. USD 4.50 Cum Pfd Registered Shs (NYSE: CTA-PB)
RKDA vs CTA-PB Comparison November 2026
Arcadia Biosciences, Inc. (NASDAQ: RKDA) plays a significant role within the Basic Materials sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RKDA stands at 337.3K. In comparison, CTA-PB has a market cap of 6.1B. Regarding current trading prices, RKDA is priced at $0.22 on the NASDAQ, while CTA-PB trades at $54.21.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RKDA currently has a P/E ratio of -0.05, whereas CTA-PB's P/E ratio is N/A. In terms of profitability, RKDA's ROE is -4.07%, compared to CTA-PB's ROE of +0.03%. Regarding short-term risk, RKDA is more volatile compared to CTA-PB. This indicates higher risk in terms of short-term price fluctuations for RKDA.Check CTA-PB's competition here
ICL Group Ltd (NYSE: ICL)
RKDA vs ICL Comparison November 2026
Arcadia Biosciences, Inc. (NASDAQ: RKDA) plays a significant role within the Basic Materials sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RKDA stands at 337.3K. In comparison, ICL has a market cap of 5.8B. Regarding current trading prices, RKDA is priced at $0.22 on the NASDAQ, while ICL trades at $4.52.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RKDA currently has a P/E ratio of -0.05, whereas ICL's P/E ratio is 10.74. In terms of profitability, RKDA's ROE is -4.07%, compared to ICL's ROE of +0.05%. Regarding short-term risk, RKDA is more volatile compared to ICL. This indicates higher risk in terms of short-term price fluctuations for RKDA.Check ICL's competition here
The Scotts Miracle-Gro Company (NYSE: SMG)
RKDA vs SMG Comparison November 2026
Arcadia Biosciences, Inc. (NASDAQ: RKDA) plays a significant role within the Basic Materials sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RKDA stands at 337.3K. In comparison, SMG has a market cap of 3.7B. Regarding current trading prices, RKDA is priced at $0.22 on the NASDAQ, while SMG trades at $63.84.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RKDA currently has a P/E ratio of -0.05, whereas SMG's P/E ratio is 14.54. In terms of profitability, RKDA's ROE is -4.07%, compared to SMG's ROE of -0.30%. Regarding short-term risk, RKDA is more volatile compared to SMG. This indicates higher risk in terms of short-term price fluctuations for RKDA.Check SMG's competition here
CVR Partners, LP (NYSE: UAN)
RKDA vs UAN Comparison November 2026
Arcadia Biosciences, Inc. (NASDAQ: RKDA) plays a significant role within the Basic Materials sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RKDA stands at 337.3K. In comparison, UAN has a market cap of 1.2B. Regarding current trading prices, RKDA is priced at $0.22 on the NASDAQ, while UAN trades at $112.60.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RKDA currently has a P/E ratio of -0.05, whereas UAN's P/E ratio is 7.40. In terms of profitability, RKDA's ROE is -4.07%, compared to UAN's ROE of +0.36%. Regarding short-term risk, RKDA is more volatile compared to UAN. This indicates higher risk in terms of short-term price fluctuations for RKDA.Check UAN's competition here
FMC Corporation (NYSE: FMC)
RKDA vs FMC Comparison November 2026
Arcadia Biosciences, Inc. (NASDAQ: RKDA) plays a significant role within the Basic Materials sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RKDA stands at 337.3K. In comparison, FMC has a market cap of 652.4M. Regarding current trading prices, RKDA is priced at $0.22 on the NASDAQ, while FMC trades at $5.21.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RKDA currently has a P/E ratio of -0.05, whereas FMC's P/E ratio is 2.04. In terms of profitability, RKDA's ROE is -4.07%, compared to FMC's ROE of -3.09%. Regarding short-term risk, RKDA is more volatile compared to FMC. This indicates higher risk in terms of short-term price fluctuations for RKDA.Check FMC's competition here
Intrepid Potash, Inc. (NYSE: IPI)
RKDA vs IPI Comparison November 2026
Arcadia Biosciences, Inc. (NASDAQ: RKDA) plays a significant role within the Basic Materials sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RKDA stands at 337.3K. In comparison, IPI has a market cap of 439.9M. Regarding current trading prices, RKDA is priced at $0.22 on the NASDAQ, while IPI trades at $32.91.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RKDA currently has a P/E ratio of -0.05, whereas IPI's P/E ratio is 18.49. In terms of profitability, RKDA's ROE is -4.07%, compared to IPI's ROE of +0.05%. Regarding short-term risk, RKDA is more volatile compared to IPI. This indicates higher risk in terms of short-term price fluctuations for RKDA.Check IPI's competition here
Benson Hill, Inc. (NYSE: BHIL-WT)
RKDA vs BHIL-WT Comparison November 2026
Arcadia Biosciences, Inc. (NASDAQ: RKDA) plays a significant role within the Basic Materials sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RKDA stands at 337.3K. In comparison, BHIL-WT has a market cap of 49M. Regarding current trading prices, RKDA is priced at $0.22 on the NASDAQ, while BHIL-WT trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RKDA currently has a P/E ratio of -0.05, whereas BHIL-WT's P/E ratio is N/A. In terms of profitability, RKDA's ROE is -4.07%, compared to BHIL-WT's ROE of -0.82%. Regarding short-term risk, RKDA is less volatile compared to BHIL-WT. This indicates lower risk in terms of short-term price fluctuations for RKDA.Check BHIL-WT's competition here
China Green Agriculture, Inc. (NYSE: CGA)
RKDA vs CGA Comparison November 2026
Arcadia Biosciences, Inc. (NASDAQ: RKDA) plays a significant role within the Basic Materials sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RKDA stands at 337.3K. In comparison, CGA has a market cap of 29.3M. Regarding current trading prices, RKDA is priced at $0.22 on the NASDAQ, while CGA trades at $1.98.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RKDA currently has a P/E ratio of -0.05, whereas CGA's P/E ratio is -0.98. In terms of profitability, RKDA's ROE is -4.07%, compared to CGA's ROE of +0.14%. Regarding short-term risk, RKDA is more volatile compared to CGA. This indicates higher risk in terms of short-term price fluctuations for RKDA.Check CGA's competition here
American Vanguard Corporation (NYSE: AVD)
RKDA vs AVD Comparison November 2026
Arcadia Biosciences, Inc. (NASDAQ: RKDA) plays a significant role within the Basic Materials sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RKDA stands at 337.3K. In comparison, AVD has a market cap of 26M. Regarding current trading prices, RKDA is priced at $0.22 on the NASDAQ, while AVD trades at $0.88.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RKDA currently has a P/E ratio of -0.05, whereas AVD's P/E ratio is -3.03. In terms of profitability, RKDA's ROE is -4.07%, compared to AVD's ROE of -0.33%. Regarding short-term risk, RKDA is more volatile compared to AVD. This indicates higher risk in terms of short-term price fluctuations for RKDA.Check AVD's competition here
Lavoro Limited (NASDAQ: LVRO)
RKDA vs LVRO Comparison November 2026
Arcadia Biosciences, Inc. (NASDAQ: RKDA) plays a significant role within the Basic Materials sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RKDA stands at 337.3K. In comparison, LVRO has a market cap of 15.1M. Regarding current trading prices, RKDA is priced at $0.22 on the NASDAQ, while LVRO trades at $0.13.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RKDA currently has a P/E ratio of -0.05, whereas LVRO's P/E ratio is -0.03. In terms of profitability, RKDA's ROE is -4.07%, compared to LVRO's ROE of +11.90%. Regarding short-term risk, RKDA is more volatile compared to LVRO. This indicates higher risk in terms of short-term price fluctuations for RKDA.Check LVRO's competition here
Bioceres Crop Solutions Corp. (NASDAQ: BIOX)
RKDA vs BIOX Comparison November 2026
Arcadia Biosciences, Inc. (NASDAQ: RKDA) plays a significant role within the Basic Materials sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RKDA stands at 337.3K. In comparison, BIOX has a market cap of 13.4M. Regarding current trading prices, RKDA is priced at $0.22 on the NASDAQ, while BIOX trades at $0.21.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RKDA currently has a P/E ratio of -0.05, whereas BIOX's P/E ratio is -0.28. In terms of profitability, RKDA's ROE is -4.07%, compared to BIOX's ROE of -2.16%. Regarding short-term risk, RKDA is more volatile compared to BIOX. This indicates higher risk in terms of short-term price fluctuations for RKDA.Check BIOX's competition here
Origin Agritech Limited (NASDAQ: SEED)
RKDA vs SEED Comparison November 2026
Arcadia Biosciences, Inc. (NASDAQ: RKDA) plays a significant role within the Basic Materials sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RKDA stands at 337.3K. In comparison, SEED has a market cap of 9.3M. Regarding current trading prices, RKDA is priced at $0.22 on the NASDAQ, while SEED trades at $0.66.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RKDA currently has a P/E ratio of -0.05, whereas SEED's P/E ratio is -0.98. In terms of profitability, RKDA's ROE is -4.07%, compared to SEED's ROE of +0.88%. Regarding short-term risk, RKDA is more volatile compared to SEED. This indicates higher risk in terms of short-term price fluctuations for RKDA.Check SEED's competition here
Fort Technology Inc. (NASDAQ: FRTT)
RKDA vs FRTT Comparison November 2026
Arcadia Biosciences, Inc. (NASDAQ: RKDA) plays a significant role within the Basic Materials sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RKDA stands at 337.3K. In comparison, FRTT has a market cap of 4.5M. Regarding current trading prices, RKDA is priced at $0.22 on the NASDAQ, while FRTT trades at $0.40.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RKDA currently has a P/E ratio of -0.05, whereas FRTT's P/E ratio is -1.99. In terms of profitability, RKDA's ROE is -4.07%, compared to FRTT's ROE of -0.93%. Regarding short-term risk, RKDA is more volatile compared to FRTT. This indicates higher risk in terms of short-term price fluctuations for RKDA.Check FRTT's competition here
Save Foods, Inc. (NASDAQ: SVFD)
RKDA vs SVFD Comparison November 2026
Arcadia Biosciences, Inc. (NASDAQ: RKDA) plays a significant role within the Basic Materials sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RKDA stands at 337.3K. In comparison, SVFD has a market cap of 4.2M. Regarding current trading prices, RKDA is priced at $0.22 on the NASDAQ, while SVFD trades at $1.41.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RKDA currently has a P/E ratio of -0.05, whereas SVFD's P/E ratio is 0.07. In terms of profitability, RKDA's ROE is -4.07%, compared to SVFD's ROE of -320.66%. Regarding short-term risk, RKDA is more volatile compared to SVFD. This indicates higher risk in terms of short-term price fluctuations for RKDA.Check SVFD's competition here
Femto Technologies Inc. (NASDAQ: FMTO)
RKDA vs FMTO Comparison November 2026
Arcadia Biosciences, Inc. (NASDAQ: RKDA) plays a significant role within the Basic Materials sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RKDA stands at 337.3K. In comparison, FMTO has a market cap of 3.1M. Regarding current trading prices, RKDA is priced at $0.22 on the NASDAQ, while FMTO trades at $3.61.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RKDA currently has a P/E ratio of -0.05, whereas FMTO's P/E ratio is -0.00. In terms of profitability, RKDA's ROE is -4.07%, compared to FMTO's ROE of -2.43%. Regarding short-term risk, RKDA is less volatile compared to FMTO. This indicates lower risk in terms of short-term price fluctuations for RKDA.Check FMTO's competition here
Benson Hill, Inc. (NYSE: BHIL)
RKDA vs BHIL Comparison November 2026
Arcadia Biosciences, Inc. (NASDAQ: RKDA) plays a significant role within the Basic Materials sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RKDA stands at 337.3K. In comparison, BHIL has a market cap of 1.5M. Regarding current trading prices, RKDA is priced at $0.22 on the NASDAQ, while BHIL trades at $0.25.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RKDA currently has a P/E ratio of -0.05, whereas BHIL's P/E ratio is -0.01. In terms of profitability, RKDA's ROE is -4.07%, compared to BHIL's ROE of -0.82%. Regarding short-term risk, RKDA is more volatile compared to BHIL. This indicates higher risk in terms of short-term price fluctuations for RKDA.Check BHIL's competition here
Nexentis Technologies Inc. (NASDAQ: NXTS)
RKDA vs NXTS Comparison November 2026
Arcadia Biosciences, Inc. (NASDAQ: RKDA) plays a significant role within the Basic Materials sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RKDA stands at 337.3K. In comparison, NXTS has a market cap of 1M. Regarding current trading prices, RKDA is priced at $0.22 on the NASDAQ, while NXTS trades at $2.21.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RKDA currently has a P/E ratio of -0.05, whereas NXTS's P/E ratio is 0.27. In terms of profitability, RKDA's ROE is -4.07%, compared to NXTS's ROE of -1.61%. Regarding short-term risk, RKDA is more volatile compared to NXTS. This indicates higher risk in terms of short-term price fluctuations for RKDA.Check NXTS's competition here
Yield10 Bioscience, Inc. (NASDAQ: YTEN)
RKDA vs YTEN Comparison November 2026
Arcadia Biosciences, Inc. (NASDAQ: RKDA) plays a significant role within the Basic Materials sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RKDA stands at 337.3K. In comparison, YTEN has a market cap of 345.5K. Regarding current trading prices, RKDA is priced at $0.22 on the NASDAQ, while YTEN trades at $0.34.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RKDA currently has a P/E ratio of -0.05, whereas YTEN's P/E ratio is -0.02. In terms of profitability, RKDA's ROE is -4.07%, compared to YTEN's ROE of -15.08%. Regarding short-term risk, RKDA is less volatile compared to YTEN. This indicates lower risk in terms of short-term price fluctuations for RKDA.Check YTEN's competition here
Terra Nitrogen Co., L.P. (NYSE: TNH)
RKDA vs TNH Comparison November 2026
Arcadia Biosciences, Inc. (NASDAQ: RKDA) plays a significant role within the Basic Materials sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RKDA stands at 337.3K. In comparison, TNH has a market cap of 0. Regarding current trading prices, RKDA is priced at $0.22 on the NASDAQ, while TNH trades at $83.96.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RKDA currently has a P/E ratio of -0.05, whereas TNH's P/E ratio is 10.13. In terms of profitability, RKDA's ROE is -4.07%, compared to TNH's ROE of +0.43%. Regarding short-term risk, RKDA is more volatile compared to TNH. This indicates higher risk in terms of short-term price fluctuations for RKDA.Check TNH's competition here
Marrone Bio Innovations, Inc. (NASDAQ: MBII)
RKDA vs MBII Comparison November 2026
Arcadia Biosciences, Inc. (NASDAQ: RKDA) plays a significant role within the Basic Materials sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RKDA stands at 337.3K. In comparison, MBII has a market cap of 0. Regarding current trading prices, RKDA is priced at $0.22 on the NASDAQ, while MBII trades at $0.80.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RKDA currently has a P/E ratio of -0.05, whereas MBII's P/E ratio is -6.82. In terms of profitability, RKDA's ROE is -4.07%, compared to MBII's ROE of -0.54%. Regarding short-term risk, RKDA is less volatile compared to MBII. This indicates lower risk in terms of short-term price fluctuations for RKDA.Check MBII's competition here